104 related articles for article (PubMed ID: 20002771)
1. Validation of potential therapeutic targets in alveolar soft part sarcoma: an immunohistochemical study utilizing tissue microarray.
Lazar AJ; Lahat G; Myers SE; Smith KD; Zou C; Wang WL; Lopez-Terrada D; Lev D
Histopathology; 2009 Dec; 55(6):750-5. PubMed ID: 20002771
[TBL] [Abstract][Full Text] [Related]
2. Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas.
Aulmann S; Longerich T; Schirmacher P; Mechtersheimer G; Penzel R
Histopathology; 2007 Jun; 50(7):881-6. PubMed ID: 17543078
[TBL] [Abstract][Full Text] [Related]
3. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis-promoting gene patterns in alveolar soft part sarcoma.
Lazar AJ; Das P; Tuvin D; Korchin B; Zhu Q; Jin Z; Warneke CL; Zhang PS; Hernandez V; Lopez-Terrada D; Pisters PW; Pollock RE; Lev D
Clin Cancer Res; 2007 Dec; 13(24):7314-21. PubMed ID: 18094412
[TBL] [Abstract][Full Text] [Related]
5. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
[TBL] [Abstract][Full Text] [Related]
6. Molecular analyses of cell origin and detection of circulating tumor cells in the peripheral blood in alveolar soft part sarcoma.
Hoshino M; Ogose A; Kawashima H; Izumi T; Hotta T; Hatano H; Morita T; Otsuka H; Umezu H; Yanoma S; Tsukuda M; Endo N
Cancer Genet Cytogenet; 2009 Apr; 190(2):75-80. PubMed ID: 19380023
[TBL] [Abstract][Full Text] [Related]
7. Alveolar soft part sarcoma: a bimarker diagnostic strategy using TFE3 immunoassay and ASPL-TFE3 fusion transcripts in paraffin-embedded tumor tissues.
Pang LJ; Chang B; Zou H; Qi Y; Jiang JF; Li HA; Hu WH; Chen YZ; Liu CX; Zhang WJ; Li F
Diagn Mol Pathol; 2008 Dec; 17(4):245-52. PubMed ID: 18382356
[TBL] [Abstract][Full Text] [Related]
8. Alveolar soft part sarcoma 'revisited': clinicopathological review of 47 cases from a tertiary cancer referral centre, including immunohistochemical expression of TFE3 in 22 cases and 21 other tumours.
Rekhi B; Ingle A; Agarwal M; Puri A; Laskar S; Jambhekar NA
Pathology; 2012 Jan; 44(1):11-7. PubMed ID: 22173238
[TBL] [Abstract][Full Text] [Related]
9. Alveolar soft part sarcoma presenting with cutaneous metastases: report of a case with immunohistochemical and molecular characterization.
Moyano S; Aguilera P; Petit A; de Alava E; Mascaró JM; Palou J; Ferrando J; Alos L
J Am Acad Dermatol; 2009 Jul; 61(1):117-20. PubMed ID: 19539846
[TBL] [Abstract][Full Text] [Related]
10. Crystal-deficient alveolar soft-part sarcoma with cutaneous involvement: a case report.
Kacerovska D; Michal M; Nemcova J; Vanecek T; Kreuzberg B; Mrazkova P; Koudela K; Kazakov DV
Am J Dermatopathol; 2009 May; 31(3):272-7. PubMed ID: 19384069
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical discrimination between the ASPL-TFE3 fusion proteins of alveolar soft part sarcoma.
Vistica DT; Krosky PM; Kenney S; Raffeld M; Shoemaker RH
J Pediatr Hematol Oncol; 2008 Jan; 30(1):46-52. PubMed ID: 18176180
[TBL] [Abstract][Full Text] [Related]
12. Alveolar soft-part sarcoma of the urinary bladder with urethral recurrence: a unique case with emphasis on differential diagnoses and diagnostic utility of an immunohistochemical panel including TFE3.
Amin MB; Patel RM; Oliveira P; Cabrera R; Carneiro V; Preto M; Balzer B; Folpe AL
Am J Surg Pathol; 2006 Oct; 30(10):1322-5. PubMed ID: 17001165
[TBL] [Abstract][Full Text] [Related]
13. Response to sunitinib malate in advanced alveolar soft part sarcoma.
Stacchiotti S; Tamborini E; Marrari A; Brich S; Rota SA; Orsenigo M; Crippa F; Morosi C; Gronchi A; Pierotti MA; Casali PG; Pilotti S
Clin Cancer Res; 2009 Feb; 15(3):1096-104. PubMed ID: 19188185
[TBL] [Abstract][Full Text] [Related]
14. Alveolar soft part sarcoma--reciprocal translocation between chromosome 17q25 and Xp11. Report of a case with metastases at presentation and review of the literature.
Uppal S; Aviv H; Patterson F; Cohen S; Benevenia J; Aisner S; Hameed M
Acta Orthop Belg; 2003 Apr; 69(2):182-7. PubMed ID: 12769020
[TBL] [Abstract][Full Text] [Related]
15. Chromosome rearrangement at 17q25 and xp11.2 in alveolar soft-part sarcoma: A case report and review of the literature.
Joyama S; Ueda T; Shimizu K; Kudawara I; Mano M; Funai H; Takemura K; Yoshikawa H
Cancer; 1999 Oct; 86(7):1246-50. PubMed ID: 10506710
[TBL] [Abstract][Full Text] [Related]
16. Involvement of epidermal growth factor receptor and downstream molecules in bone and soft tissue tumors.
Dobashi Y; Suzuki S; Sugawara H; Ooi A
Hum Pathol; 2007 Jun; 38(6):914-25. PubMed ID: 17376509
[TBL] [Abstract][Full Text] [Related]
17. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
[TBL] [Abstract][Full Text] [Related]
18. Alveolar Soft Part Sarcoma.
Jaber OI; Kirby PA
Arch Pathol Lab Med; 2015 Nov; 139(11):1459-62. PubMed ID: 26516944
[TBL] [Abstract][Full Text] [Related]
19. Endothelial cell KIT expression in human tumours.
Sihto H; Tynninen O; Bützow R; Saarialho-Kere U; Joensuu H
J Pathol; 2007 Mar; 211(4):481-8. PubMed ID: 17294421
[TBL] [Abstract][Full Text] [Related]
20. Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets.
Cimbaluk D; Rotmensch J; Scudiere J; Gown A; Bitterman P
Gynecol Oncol; 2007 Apr; 105(1):138-44. PubMed ID: 17175012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
